Physician profile
Gregory J Precht
NPI 1164653580
$4,045.08
in general payments reported to CMS, 2019-2025
44 companies · $654 in 2025
The $654 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $925 · 2020: $402 · 2021: $506 · 2022: $682 · 2023: $441 · 2024: $436 · 2025: $654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,486 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,485.70 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $518.26 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $492.37 | 2021-2025 | |
| Novo Nordisk INC | $450.63 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $416.67 | 2019-2023 | Prolia, Evenity |
| Pfizer INC. | $192.56 | 2019-2023 | |
| Astrazeneca Pharmaceuticals Lp | $170.69 | 2019-2025 | Breztri, Airsupra |
| Takeda Pharmaceuticals U.S.A., INC. | $148.79 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $131.85 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $126.70 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $98.65 | 2019-2025 | Spravato, Invega Sustenna |
| Bayer Healthcare Pharmaceuticals INC. | $98.09 | 2021-2024 | |
| Astellas Pharma US INC | $94.51 | 2022-2025 | Veozah |
| Merck Sharp & Dohme LLC | $94.06 | 2020-2024 | Gardasil 9, Vaxelis, Capvaxive |
| Kowa Pharmaceuticals America, INC. | $92.03 | 2019-2023 | Seglentis, Livalo |
| Sanofi-Aventis U.S. LLC | $79.26 | 2019-2025 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Precht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.